SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001171843-15-002137
Filing Date
2015-04-23
Accepted
2015-04-23 16:05:14
Documents
4
Period of Report
2015-06-03
Effectiveness Date
2015-04-23

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a_042315.htm DEF 14A 784021
2 cheung.gif GRAPHIC 2878
3 pcard_1.jpg GRAPHIC 123714
4 pcard_2.jpg GRAPHIC 139728
  Complete submission text file 0001171843-15-002137.txt   1152511
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-14027 | Film No.: 15788488
SIC: 3841 Surgical & Medical Instruments & Apparatus